Better medicine through diversity
Target physicians treating more diverse patient populations to enhance clinical trials and health
plan networks
One report, two million providers
With the importance of equity, inclusion, diversity and belonging taking center stage in the national debate on healthcare, HealthVerity realized that its real-world data (RWD) ecosystem was ideally suited to respond to the challenge. The HealthVerity Provider Diversity and Diagnosis Index (PDI) Masterset is the only nationally syndicated report that leverages medical, pharmacy and consumer data to calculate the racial diversity, demographic mix and diagnosis of patients for over 2 million healthcare providers, as well as the race of the provider, all in a HIPAA-compliant manner. The PDI has become the definitive guide for a wide range of diversity-challenged endeavors, such as clinical trial investigator recruiting and health plan network building.
Broaden choices for clinical trial investigators
Instantly assess the demographic composition of a healthcare provider’s patient population, including race, age, gender, income and payer type to ascertain if the physician would make an optimal investigator for your clinical trial. PDI also provides diagnosis codes so you know the demographic composition of patients being treated for the specific disease state you’re studying.
Meet FDA guidance
Ensure alignment with the latest guidance from the FDA regarding the need to increase participation from underrepresented racial and ethnic populations in clinical trials.
Diversify provider networks
Determine if the providers in your network best reflect the diversity of the areas they serve by comparing Census data for geographic areas of key physician specialties with their computed demographic mix.
Experience how you can ensure equity
Sync diversity
Diversity on demand: How to meet new FDA guidance for clinical trials
The FDA recently released draft guidance on creating Diversity Action Plans for clinical trials as part of an ongoing effort to ensure clinical trials represent populations that will benefit most from medical products. Read our blog post to learn how PDI offers a single solution to help pharma companies meet this soon-to-be-required guidance.
Synchronizing diversity in clinical trials
This informative webinar explores enhancements to the 2023 PDI, including age, gender, income, payer type and diagnosis code, creating a HIPAA-compliant guide for discovering optimal clinical investigators treating more diverse populations.
Sync up diversity in clinical trials
Clinical trials are out of sync, rarely including participants in ethnic proportion to those actually diagnosed with the condition being studied, creating gaps in knowledge that impact outcomes.